Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
- PMID: 28584183
- DOI: 10.1158/0008-5472.CAN-17-0165
Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
Abstract
Understanding the genetic basis of cancer has led to therapies that _target driver mutations and has helped match patients with more personalized drugs. Oncogenic mutations influence tumor metabolism, but other tumor characteristics can also contribute to their metabolic phenotypes. Comparison of isogenic lung and pancreas tumor models suggests that use of some metabolic pathways is defined by lineage rather than by driver mutation. Lung tumors catabolize circulating branched chain amino acids (BCAA) to extract nitrogen for nonessential amino acid and nucleotide synthesis, whereas pancreatic cancer obtains amino acids from catabolism of extracellular protein. These differences in amino acid metabolism translate into distinct pathway dependencies, as genetic disruption of the enzymes responsible for utilization of BCAA nitrogen limits the growth of lung tumors, but not pancreatic tumors. These data argue that some cancer metabolic phenotypes are defined by cancer tissue-of-origin and environment and that these features constrain the influence of genetic mutations on metabolism. A better understanding of the factors defining tumor nutrient utilization could be exploited to help improve cancer therapy. Cancer Res; 77(12); 3131-4. ©2017 AACR.
©2017 American Association for Cancer Research.
Similar articles
-
Towards a metabolic therapy of cancer?Acta Biomed. 2012 Dec;83(3):168-76. Acta Biomed. 2012. PMID: 23762991 Review.
-
Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?Cancer Res. 2016 Sep 15;76(18):5195-200. doi: 10.1158/0008-5472.CAN-16-0141. Cancer Res. 2016. PMID: 27635042 Review.
-
The Emerging Hallmarks of Cancer Metabolism.Cell Metab. 2016 Jan 12;23(1):27-47. doi: 10.1016/j.cmet.2015.12.006. Cell Metab. 2016. PMID: 26771115 Free PMC article. Review.
-
_targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context.Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):76-87. doi: 10.1016/j.bbcan.2018.05.002. Epub 2018 May 23. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29775654 Free PMC article. Review.
-
Metabolic network adaptations in cancer as _targets for novel therapies.Biochem Soc Trans. 2010 Oct;38(5):1302-6. doi: 10.1042/BST0381302. Biochem Soc Trans. 2010. PMID: 20863303
Cited by
-
Research progress on branched-chain amino acid aminotransferases.Front Genet. 2023 Nov 6;14:1233669. doi: 10.3389/fgene.2023.1233669. eCollection 2023. Front Genet. 2023. PMID: 38028625 Free PMC article. Review.
-
Mitochondrial oncobioenergetics of prostate tumorigenesis.Oncol Lett. 2019 Nov;18(5):4367-4376. doi: 10.3892/ol.2019.10785. Epub 2019 Aug 27. Oncol Lett. 2019. PMID: 31611945 Free PMC article. Review.
-
Cancer as a Disease of Development Gone Awry.Annu Rev Pathol. 2024 Jan 24;19:397-421. doi: 10.1146/annurev-pathmechdis-031621-025610. Epub 2023 Oct 13. Annu Rev Pathol. 2024. PMID: 37832945 Free PMC article. Review.
-
Computational Oncology in the Multi-Omics Era: State of the Art.Front Oncol. 2020 Apr 7;10:423. doi: 10.3389/fonc.2020.00423. eCollection 2020. Front Oncol. 2020. PMID: 32318338 Free PMC article. Review.
-
Metabolic Footprints and Molecular Subtypes in Breast Cancer.Dis Markers. 2017;2017:7687851. doi: 10.1155/2017/7687851. Epub 2017 Dec 24. Dis Markers. 2017. PMID: 29434411 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases